This is a preview of subscription content, log in via an institution to check access.
References
Tempero MA (2019) NCCN Guidelines Updates: Pancreatic Cancer. 17: 603
National Cancer Institute (2019) Advances in Pancreatic Cancer Research. retrieved: 09/06/2019; Available from: https://www.cancer.gov/types/pancreatic/research.
O’Hara MH, O’Reilly EM, Rosemarie M, et al (2019) Abstract CT004: A Phase Ib study of CD40 agonistic monoclonal antibody APX005M together with gemcitabine (Gem) and nab-paclitaxel (NP) with or without nivolumab (Nivo) in untreated metastatic ductal pancreatic adenocarcinoma (PDAC) patients. Cancer Research 79: CT004-CT004
National Comprehensive Cancer Network (2019) Pancreatic Adenocarcinoma (Version 3.2019). retrieved: 09/06/2019; Available from: https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf.
Murphy JE, Wo JY, Ryan DP, et al (2019) Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial. JAMA Oncol 5: 1020-1027
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Report from the pancreatic ductal adenocarcinoma disease focused panel. Abdom Radiol 44, 4002–4003 (2019). https://doi.org/10.1007/s00261-019-02261-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-019-02261-3